These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

5995 related articles for article (PubMed ID: 32085846)

  • 1. Pathological findings of COVID-19 associated with acute respiratory distress syndrome.
    Xu Z; Shi L; Wang Y; Zhang J; Huang L; Zhang C; Liu S; Zhao P; Liu H; Zhu L; Tai Y; Bai C; Gao T; Song J; Xia P; Dong J; Zhao J; Wang FS
    Lancet Respir Med; 2020 Apr; 8(4):420-422. PubMed ID: 32085846
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of coronavirus disease 2019 induced acute respiratory distress syndrome is different from traditional acute respiratory distress syndrome].
    Pan C; Xie JF; Qiu HB; Yang Y
    Zhonghua Shao Shang Za Zhi; 2020 May; 36(5):330-333. PubMed ID: 32456368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparison of clinical and pathological features between severe acute respiratory syndrome and coronavirus disease 2019].
    Zhang T; Sun LX; Feng RE
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 Jun; 43(6):496-502. PubMed ID: 32241072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stem cells as living anti-inflammatory therapy for COVID-19 related acute respiratory distress syndrome.
    Lin F; Ichim TE; Pingle S; Jones LD; Kesari S; Ashili S
    World J Stem Cells; 2020 Oct; 12(10):1067-1079. PubMed ID: 33178392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of
    Schloss J; Leach M; Brown D; Hannan N; Kendall-Reed P; Steel A
    Adv Integr Med; 2020 Dec; 7(4):232-239. PubMed ID: 32837898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pro- and Anti-Inflammatory Responses in Severe COVID-19-Induced Acute Respiratory Distress Syndrome-An Observational Pilot Study.
    Notz Q; Schmalzing M; Wedekink F; Schlesinger T; Gernert M; Herrmann J; Sorger L; Weismann D; Schmid B; Sitter M; Schlegel N; Kranke P; Wischhusen J; Meybohm P; Lotz C
    Front Immunol; 2020; 11():581338. PubMed ID: 33123167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-17A and TNF-α as potential biomarkers for acute respiratory distress syndrome and mortality in patients with obesity and COVID-19.
    Leija-Martínez JJ; Huang F; Del-Río-Navarro BE; Sanchéz-Muñoz F; Muñoz-Hernández O; Giacoman-Martínez A; Hall-Mondragon MS; Espinosa-Velazquez D
    Med Hypotheses; 2020 Nov; 144():109935. PubMed ID: 32795834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide inhalation as an interventional rescue therapy for COVID-19-induced acute respiratory distress syndrome.
    Kobayashi J; Murata I
    Ann Intensive Care; 2020 May; 10(1):61. PubMed ID: 32436029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ruxolitinib Rapidly Reduces Acute Respiratory Distress Syndrome in COVID-19 Disease. Analysis of Data Collection From RESPIRE Protocol.
    Capochiani E; Frediani B; Iervasi G; Paolicchi A; Sani S; Roncucci P; Cuccaro A; Franchi F; Simonetti F; Carrara D; Bertaggia I; Nasso D; Riccioni R; Scolletta S; Valente S; Conticini E; Gozzetti A; Bocchia M
    Front Med (Lausanne); 2020; 7():466. PubMed ID: 32850921
    [No Abstract]   [Full Text] [Related]  

  • 10. Lung Mechanics in COVID-19 Resemble Respiratory Distress Syndrome, Not Acute Respiratory Distress Syndrome: Could Surfactant Be a Treatment?
    Koumbourlis AC; Motoyama EK
    Am J Respir Crit Care Med; 2020 Aug; 202(4):624-626. PubMed ID: 32579022
    [No Abstract]   [Full Text] [Related]  

  • 11. Respiratory management of adult patients with acute respiratory distress syndrome due to COVID-19.
    Makkar P; Pastores SM
    Respirology; 2020 Nov; 25(11):1133-1135. PubMed ID: 32929786
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased physiological dead space in mechanically ventilated COVID-19 patients recovering from severe acute respiratory distress syndrome: a case report.
    Xia J; Feng Y; Li M; Yu X; Zhang Y; Duan J; Zhan Q
    BMC Infect Dis; 2020 Aug; 20(1):637. PubMed ID: 32854630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What every intensivist should know about acute respiratory distress syndrome and diffuse alveolar damage.
    Rios F; Iscar T; Cardinal-Fernández P
    Rev Bras Ter Intensiva; 2017; 29(3):354-363. PubMed ID: 28977098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the Clinical Course of COVID-19 Pneumonia and Acute Respiratory Distress Syndrome in 2 Passengers from the Cruise Ship Diamond Princess in February 2020.
    Matsumura K; Toyoda Y; Matsumoto S; Kawai Y; Mori T; Omasa K; Fukada T; Yamada M; Kazamaki T; Furugori S; Hiroe N; Senoo S; Shimizu M; Funabiki T; Yamazaki M
    Am J Case Rep; 2020 Aug; 21():e926835. PubMed ID: 32811804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Consideration of prevention and management of long-term consequences of post-acute respiratory distress syndrome in patients with COVID-19.
    Candan SA; Elibol N; Abdullahi A
    Physiother Theory Pract; 2020 Jun; 36(6):663-668. PubMed ID: 32419564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Case of Extracorporeal Membrane Oxygenation as a Salvage Therapy for COVID-19-Associated Severe Acute Respiratory Distress Syndrome: Mounting Evidence.
    Rajdev K; Farr LA; Saeed MA; Hooten R; Baus J; Boer B
    J Investig Med High Impact Case Rep; 2020; 8():2324709620957778. PubMed ID: 32911986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expect.
    Can A; Coskun H
    Stem Cells Transl Med; 2020 Nov; 9(11):1287-1302. PubMed ID: 32779878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and Management of Acute Respiratory Distress Syndrome in a Time of COVID-19.
    Kassirian S; Taneja R; Mehta S
    Diagnostics (Basel); 2020 Dec; 10(12):. PubMed ID: 33291238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothesis for the management and treatment of the COVID-19-induced acute respiratory distress syndrome and lung injury using mesenchymal stem cell-derived exosomes.
    Taghavi-Farahabadi M; Mahmoudi M; Soudi S; Hashemi SM
    Med Hypotheses; 2020 Nov; 144():109865. PubMed ID: 32562911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two False Negative Test Results in a Symptomatic Patient with a Confirmed Case of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) and Suspected Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN).
    Lagziel T; Quiroga L; Ramos M; Hultman CS; Asif M
    Cureus; 2020 May; 12(5):e8198. PubMed ID: 32455090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 300.